Category Archives: Inside BIO Industry Analysis

Therapeutic Licensing and M&A Deals

lab_tech

Licensing deals for therapeutic candidates in 2013 dropped to the lowest volume in at least eight years for deals with disclosed values totaling over $10M. Total upfront payments to biotechs were also at an eight year low, with only $1.9B paid to biotechs in 2013. This is a 50 percent drop from peak levels. However, there is a silver lining in the data: Preclinical deal volume saw a slight increase in 2013, and has not Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , , ,

Debunking the Biotech Bubble Talk

Chart

The Nasdaq Biotechnology Index (NBI) has been on a wild ride in 2014 with a 20 percent gain in the first two months, a 24 percent drop from late February to mid-April, and a rebound of 16 percent off April lows by early June. This recent sell-off follows a 130 percent gain over the last three years and the debut of 100 biotech IPOs, leading some investors to ask if the recent sell-off is the Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , , , ,

RFS: Shifting Focus on to Climate Change

Gas-Can-Spilling-Corn-115x76

Dueling studies highlight focus on climate impacts of renewable fuel standard. In a recent ClimateWire piece, Environment & Energy reporters Tiffany Stecker and Julia Pyper, highlighted two opposing stances on whether or not biofuels contribute to the increase of greenhouse gas emissions. The Environmental Working Group released a study late June that found U.S. EPA’s proposed cut in the amount of ethanol would “prevent 3 million tons of carbon dioxide from entering the atmosphere — the Read More >

Biofuels & Climate Change  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

BIO Innovation Zone Company Snapshots: Humanetics Corporation

InnovationZone_Logo_SBIR Companies_VERT_lockup

Next month in San Diego at the BIO International Convention, BIO will be partnering with the National Institutes of Health (NIH) and the National Science foundation (NSF) to host the first-ever BIO Innovation Zone. The Zone will feature Small Business Innovation Research (SBIR) funded early-stage biotech companies. The SBIR/STTR program provides U.S. federal funding to small businesses engaged in research with the potential for commercialization. Companies are rigorously vetted through the NIH and NSF SBIR review process prior to Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

ARPA-E Innovation Summit Comes to Washington, DC.

arpa-e-logo

The U.S. Department of Energy’s ARPA-E Innovation Summit is scheduled for February 24-26, 2014 in Washington, DC. The Advanced Research Projects Agency-Energy (ARPA-E) funds transformational projects that create entirely new ways to generate, store, and use energy. Since September 2013, ARPA-E has announced almost $125 million in funding for new projects aimed at finding innovative ways to lower the cost and improve the efficiency of energy technologies. “We’re investing in the best people, the best Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , , ,